The question of when a COVID-19 vaccine might be available is perhaps the most pressing in the world. There have been a number of recent headlines on this front, including early but encouraging results from trials. And on Wednesday, the Trump administration awarded a contract to Pfizer and a German biotech firm to potentially deliver doses this year. Miles O’Brien joins Judy Woodruff to discuss.
Stream your PBS favorites with the PBS app:
Find more from PBS NewsHour at
Subscribe to our YouTube channel:
Follow us:
Facebook:
Twitter:
Instagram:
Snapchat: @pbsnews
Subscribe:
PBS NewsHour podcasts:
Newsletters:
